These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6339379)

  • 21. Quantitation of antibody-secreting cells in the blood after vaccination with Haemophilus influenzae type b conjugate vaccine.
    Barington T; Heilmann C; Andersen V
    Scand J Immunol; 1990 Apr; 31(4):515-22. PubMed ID: 2185534
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pneumococcal conjugate vaccination in toddlers: mucosal antibody response measured as circulating antibody-secreting cells and as salivary antibodies.
    Nieminen T; Käyhty H; Leroy O; Eskola J
    Pediatr Infect Dis J; 1999 Sep; 18(9):764-72. PubMed ID: 10493335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunoglobulins in the hyperimmunoglobulin E and recurrent infection (Job's) syndrome. Deficiency of anti-Staphylococcus aureus immunoglobulin A.
    Dreskin SC; Goldsmith PK; Gallin JI
    J Clin Invest; 1985 Jan; 75(1):26-34. PubMed ID: 3871199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Response of 7- to 15-month-old infants to sequential immunization with Haemophilus influenzae type b-CRM197 conjugate and polysaccharide vaccines.
    Rothstein EP; Schiller RP; Girone JA; Hipp TJ; Souder RL; Bernstein HH; Madore DV; Johnson CL; Smith DH
    Am J Dis Child; 1991 Aug; 145(8):898-900. PubMed ID: 1858727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Duration of serum antibodies elicited by Haemophilus influenzae type b capsular polysaccharide alone or conjugated to tetanus toxoid in 18- to 23-month-old children.
    Claesson BA; Schneerson R; Trollfors B; Lagergård T; Taranger J; Robbins JB
    J Pediatr; 1990 Jun; 116(6):929-31. PubMed ID: 2348298
    [No Abstract]   [Full Text] [Related]  

  • 26. Oral non-typable Haemophilus influenzae enhances physiological mechanism of airways protection.
    Clancy RL; Dunkley ML
    Clin Exp Immunol; 2010 Jul; 161(1):127-33. PubMed ID: 20408861
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunization of 2-month-old infants with protein-coupled oligosaccharides derived from the capsule of Haemophilus influenzae type b.
    Anderson P; Pichichero ME; Insel RA
    J Pediatr; 1985 Sep; 107(3):346-51. PubMed ID: 3875705
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune response in the lungs following oral immunization with bacterial lysates of respiratory pathogens.
    Ruedl C; Frühwirth M; Wick G; Wolf H
    Clin Diagn Lab Immunol; 1994 Mar; 1(2):150-4. PubMed ID: 7496936
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Salivary antibodies following parenteral immunization of infants with a meningococcal serogroup A and C conjugated vaccine.
    Borrow R; Fox AJ; Cartwright K; Begg NT; Jones DM
    Epidemiol Infect; 1999 Oct; 123(2):201-8. PubMed ID: 10579438
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunogenicity of four Haemophilus influenzae type b conjugate vaccines in 17- to 19-month-old children.
    Holmes SJ; Murphy TV; Anderson RS; Kaplan SL; Rothstein EP; Gan VN; Granoff DM
    J Pediatr; 1991 Mar; 118(3):364-71. PubMed ID: 1999775
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systemic immunization with pneumococcal polysaccharide vaccine induces a predominant IgA2 response of peripheral blood lymphocytes and increases of both serum and secretory anti-pneumococcal antibodies.
    Lue C; Tarkowski A; Mestecky J
    J Immunol; 1988 Jun; 140(11):3793-800. PubMed ID: 3372993
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between naturally occurring human mucosal and serum antibody to the capsular polysaccharide of Haemophilus influenzae type b.
    Pichichero ME; Insel RA
    J Infect Dis; 1982 Aug; 146(2):243-8. PubMed ID: 6980956
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An ELISA employing a Haemophilus influenzae type b oligosaccharide-human serum albumin conjugate correlates with the radioantigen binding assay.
    Phipps DC; West J; Eby R; Koster M; Madore DV; Quataert SA
    J Immunol Methods; 1990 Dec; 135(1-2):121-8. PubMed ID: 2273252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunoglobulin production in man stimulated by an orally administered bacterial lysate.
    Puigdollers JM; Serna GR; Hernandez del Rey I; Barruffet MT; Torroella JJ
    Respiration; 1980; 40(3):142-9. PubMed ID: 7003667
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mucosal antibodies to Haemophilus influenzae type b capsular polysaccharide.
    Gilsdorf JR; McDonnell WM
    Pediatr Res; 1991 May; 29(5):420-3. PubMed ID: 1896245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isotype distribution and bactericidal activity of antibodies after immunization with Haemophilus influenzae type b vaccines at 18-24 months of age.
    Käyhty H; Mäkelä O; Eskola J; Saarinen L; Seppälä I
    J Infect Dis; 1988 Nov; 158(5):973-82. PubMed ID: 3053931
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhancement of nasal clearance of nontypeable Haemophilus influenzae by oral immunization with outer membrane proteins.
    Suzuki M; Kurono Y; Kodama S; Shigemi H; Mogi G
    Acta Otolaryngol; 1998 Nov; 118(6):864-9. PubMed ID: 9870635
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunogenicity of Haemophilus influenzae type b polysaccharide-tetanus toxoid conjugate vaccine in infants.
    Holmes SJ; Fritzell B; Guito KP; Esbenshade JF; Blatter MM; Reisinger KS; Keyserling HL; Rothstein EP; Bernstein HH; Feldman S
    Am J Dis Child; 1993 Aug; 147(8):832-6. PubMed ID: 8352217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective defect in the antibody response to Haemophilus influenzae type b in children with recurrent infections and normal serum IgG subclass levels.
    Ambrosino DM; Umetsu DT; Siber GR; Howie G; Goularte TA; Michaels R; Martin P; Schur PH; Noyes J; Schiffman G
    J Allergy Clin Immunol; 1988 Jun; 81(6):1175-9. PubMed ID: 3259962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Immunovac-VP-4 for prevention of acute respiratory diseases in children's communities].
    Egorova NB; Kurbatova EA; Gruber IM; Semenova IB
    Zh Mikrobiol Epidemiol Immunobiol; 2010; (6):35-40. PubMed ID: 21381375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.